110 related articles for article (PubMed ID: 26925434)
1. An emerging question about putative cancer stem cells in established cell lines-are they true stem cells or a fluctuating cell phenotype?
Gunjal P; Pedziwiatr D; Ismail AA; Kakar SS; Ratajczak MZ
J Cancer Stem Cell Res; 2015; 3():. PubMed ID: 26925434
[TBL] [Abstract][Full Text] [Related]
2. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.
Wright MH; Calcagno AM; Salcido CD; Carlson MD; Ambudkar SV; Varticovski L
Breast Cancer Res; 2008; 10(1):R10. PubMed ID: 18241344
[TBL] [Abstract][Full Text] [Related]
3. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.
Sellers ZP; Schneider G; Bujko K; Suszynska M; Pedziwiatr D
Stem Cell Rev Rep; 2017 Oct; 13(5):603-610. PubMed ID: 28624968
[TBL] [Abstract][Full Text] [Related]
4. CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells.
Liu H; Wang YJ; Bian L; Fang ZH; Zhang QY; Cheng JX
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1745-54. PubMed ID: 27212166
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
7. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
Nakshatri H; Srour EF; Badve S
Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
[TBL] [Abstract][Full Text] [Related]
9. [Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].
Lu YH; Zhu H; Wang ZW; Fan XJ; Zhu SJ; Li XH; Wang Y; Lu JJ; Zhu MY
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3107-10. PubMed ID: 22340650
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells.
Nami B; Ghasemi-Dizgah A; Vaseghi A
Bioimpacts; 2016; 6(2):105-10. PubMed ID: 27525228
[TBL] [Abstract][Full Text] [Related]
11. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
[TBL] [Abstract][Full Text] [Related]
12. Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines.
Enciso-Benavides J; Alfaro L; Castañeda-Altamirano C; Rojas N; González-Cabeza J; Enciso N; Riesco F; Castillo M; Enciso J
Heliyon; 2021 Jun; 7(6):e07273. PubMed ID: 34235281
[TBL] [Abstract][Full Text] [Related]
13. ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.
Adams A; Warner K; Pearson AT; Zhang Z; Kim HS; Mochizuki D; Basura G; Helman J; Mantesso A; Castilho RM; Wicha MS; Nör JE
Oncotarget; 2015 Sep; 6(29):26633-50. PubMed ID: 26449187
[TBL] [Abstract][Full Text] [Related]
14. Features of CD44+/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast.
Gudadze M; Kankava Q; Mariamidze A; Burkadze G
Georgian Med News; 2014 Mar; (228):81-7. PubMed ID: 24743129
[TBL] [Abstract][Full Text] [Related]
15. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
16. Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.
Chiu CC; Lee LY; Li YC; Chen YJ; Lu YC; Li YL; Wang HM; Chang JT; Cheng AJ
Cancer Gene Ther; 2013 Nov; 20(11):606-15. PubMed ID: 24201869
[TBL] [Abstract][Full Text] [Related]
17. Increased invasion and tumorigenicity capacity of CD44+/CD24- breast cancer MCF7 cells in vitro and in nude mice.
Yan W; Chen Y; Yao Y; Zhang H; Wang T
Cancer Cell Int; 2013 Jun; 13(1):62. PubMed ID: 23799994
[TBL] [Abstract][Full Text] [Related]
18. [Cancer stem cells: its existence, proliferation and differentiation in an adenoid cystic carcinoma cell line].
Liu K; Hua CG; Wen YM; Pan J; Chen SW; Gao QH
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):284-7. PubMed ID: 17686280
[TBL] [Abstract][Full Text] [Related]
19. Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44(+)/CD24(-/low) Stem Cell Phenotype.
Gao X; Sishc BJ; Nelson CB; Hahnfeldt P; Bailey SM; Hlatky L
Front Oncol; 2016; 6():138. PubMed ID: 27379202
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
